FARALLON CAPITAL MANAGEMENT, L.L.C.
SAN FRANCISCO, CA · CIK 909661 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 1996 · limited liability company
- Assets managed$52.1bn
- Staff355 · 129 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds50 (50 hedge) · $64.5bn gross assets
- Websitefaralloncapital.com
- Form ADV · 2026-09-23SEC adviser record
- Legal entityFARALLON CAPITAL MANAGEMENT, L.L.C. (US)
$17.1bn
reported value
+1.3% vs Q1 2026
86positions
55.7%in top 10
0 new
29 added
23 reduced
104 sold out
vs Q1 2026
This manager withheld holdings under SEC confidential treatment in Q1 2026, so positions that look new may have been held then. They're marked "Not comparable".
Options: 1 call positions ($28.4m notional), 2 put positions ($4.6bn notional) – listed below, not included above.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| REVOLUTION MEDICINES INC RVMD | $2.5bn14.86% | Reduced -54.0k |
| ELECTRONIC ARTS INC EA | $1.6bn9.51% | Added +449.5k |
| BRIDGEBIO PHARMA INC BBIO | $800.1m4.68% | Added +1.4m |
| PROTAGONIST THERAPEUTICS INC PTGX | $778.2m4.56% | Unchanged |
| EXELIXIS INC EXEL | $732.8m4.29% | Added +357.0k |
| LIQUIDIA CORPORATION LQDA | $666.9m3.90% | Reduced -291.0k |
| AMAZON COM INC AMZN | $627.5m3.67% | Reduced -1.6m |
| LANTHEUS HLDGS INC LNTH | $619.4m3.63% | Unchanged |
| NATERA INC NTRA | $602.2m3.52% | Reduced -989.0k |
| UNITEDHEALTH GROUP INC UNH | $528.1m3.09% | Reduced -551.2k |
| THERMO FISHER SCIENTIFIC INC TMO | $526.0m3.08% | Added +167.7k |
| ROIVANT SCIENCES LTD ROIV | $506.4m2.96% | Added +4.6m |
| AON PLC AON | $458.6m2.68% | Reduced -1.1m |
| BOSTON SCIENTIFIC CORP BSX | $449.0m2.63% | Added +3.1m |
| BROADCOM INC AVGO | $435.1m2.55% | Reduced -627.7k |
| MICROSOFT CORP MSFT | $415.1m2.43% | Reduced -1.2m |
| TANGO THERAPEUTICS INC TNGX | $383.8m2.25% | Added +3.2m |
| KKR & CO INC KKR | $378.0m2.21% | Reduced -553.5k |
| SYNOPSYS INC SNPS | $370.1m2.17% | Reduced -383.7k |
| BEAM THERAPEUTICS INC BEAM | $351.3m2.06% | Added +101.7k |
| CRINETICS PHARMACEUTICALS IN CRNX | $336.4m1.97% | Added +651.0k |
| GRAIL INC GRAL | $284.1m1.66% | Added +907.9k |
| WABTEC WAB | $241.2m1.41% | Reduced -714.9k |
| IMMUNOVANT INC IMVT | $223.7m1.31% | Added +4.3m |
| TWIST BIOSCIENCE CORP TWST | $219.8m1.29% | Added +708.8k |
| AGIOS PHARMACEUTICALS INC AGIO | $219.6m1.29% | Added +233.4k |
| ARAMARK ARMK | $206.3m1.21% | Reduced -2.5m |
| BAIDU INC BIDU | $137.6m0.81% | Added +760.0k |
| NOVO-NORDISK A S NVO | $125.6m0.73% | Added +1.8m |
| ACADIA HEALTHCARE COMPANY IN ACHC | $124.6m0.73% | Added +2.5m |
| BRIGHTSPRING HEALTH SVCS INC BTSG | $120.8m0.71% | Added +115.8k |
| ASTRAZENECA PLC AZN | $108.8m0.64% | Added +347.5k |
| JOHNSON & JOHNSON JNJ | $103.6m0.61% | Added +260.0k |
| STRATEGY INC MSTR 0 12.01.29 · principal | $75.4m0.44% | Added +48.4m |
| PARABILIS MEDICINES INC PBLS | $64.8m0.38% | Not comparable |
| NOVARTIS AG NVS | $56.9m0.33% | Not comparable |
| GUARDANT HEALTH INC GH | $48.3m0.28% | Added +314.2k |
| VNET GROUP INC VNET 2 10.01.27 · principal | $46.8m0.27% | Unchanged |
| AVALO THERAPEUTICS INC AVTX | $46.2m0.27% | Added +1.6m |
| JOYY INC JOYY | $46.1m0.27% | Added +121.0k |
| ASSEMBLY BIOSCIENCES INC ASMB | $44.1m0.26% | Added +377.0k |
| ENANTA PHARMACEUTICALS INC ENTA | $35.3m0.21% | Reduced -453.7k |
| MAZE THERAPEUTICS INC MAZE | $33.1m0.19% | Added +734.8k |
| MERCK & CO INC MRK | $25.6m0.15% | Reduced -162.0k |
| WARBY PARKER INC WRBY | $25.1m0.15% | Not comparable |
| PERCEPTIVE CAP SOLUTIONS COR FRNM | $24.5m0.14% | Unchanged |
| KAILERA THERAPEUTICS INC KLRA | $24.2m0.14% | Not comparable |
| RIO TINTO PLC RIO | $17.4m0.10% | Added +129.7k |
| AXALTA COATING SYS LTD AXTA | $16.4m0.10% | Not comparable |
| ABIVAX SA ABVX | $16.3m0.10% | Added +120.0k |
| VNET GROUP INC VNET | $16.0m0.09% | Added +1.4m |
| NETEASE INC NTES | $15.8m0.09% | Reduced -167.7k |
| BIOGEN INC BIIB | $15.3m0.09% | Not comparable |
| TAYSHA GENE THERAPIES INC TSHA | $15.3m0.09% | Not comparable |
| MOBIA MED INC MOBI | $15.1m0.09% | Not comparable |
| STRATEGY INC MSTR 2.25 06.15.32 · principal | $14.2m0.08% | Not comparable |
| MINERVA NEUROSCIENCES INC NERV | $13.1m0.08% | Unchanged |
| ALAMAR BIOSCIENCES INC ALMR | $12.5m0.07% | Not comparable |
| ALVOTECH ALVO | $10.6m0.06% | Added +2.7m |
| BETA BIONICS INC BBNX | $9.3m0.05% | Reduced -3.0m |
| INFLARX NV IFRX | $7.4m0.04% | Not comparable |
| SCOTTS MIRACLE-GRO CO SMG | $6.0m0.04% | Not comparable |
| WAYSTAR HLDG CORP WAY | $5.4m0.03% | Not comparable |
| BRUNSWICK CORP BC | $5.1m0.03% | Not comparable |
| GENTEX CORP GNTX | $5.0m0.03% | Not comparable |
| IDEXX LABS INC IDXX | $4.7m0.03% | Not comparable |
| PRIME MEDICINE INC PRME | $4.6m0.03% | Unchanged |
| COMMERCIAL METALS CO CMC | $4.2m0.02% | Not comparable |
| JATT II ACQUISITION CORP JATT | $3.4m0.02% | Not comparable |
| SAGIMET BIOSCIENCES INC SGMT | $3.2m0.02% | Not comparable |
| STRATEGY INC MSTR 0 03.01.30 · principal | $2.3m0.01% | Not comparable |
| SUMMIT MIDSTREAM CORPORATION SMC | $1.7m0.01% | Unchanged |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | $1.4m0.01% | Reduced -314.0k |
| REVOLUTION MEDICINES INC RVMDW | $1.1m0.01% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $657.9k0.00% | Unchanged |
| ALEANNA INC ANNAW | $297.0k0.00% | Unchanged |
| ALEANNA INC ANNA | $227.4k0.00% | Unchanged |
| WELLTOWER INC WELL | $227.0k0.00% | Reduced -199.0k |
| SOLID POWER INC SLDPW | $41.4k0.00% | Unchanged |
| BLUE GOLD LTD BGLWW | $30.7k0.00% | Reduced -44.2k |
| PACIFIC BIOSCIENCES CALIF IN PACB | $23.9k0.00% | Reduced -120.8k |
| GERON CORP GERN | $18.4k0.00% | Reduced -28.6k |
| NVNI GROUP LIMITED NVNWF | $17.6k0.00% | Unchanged |
| CANOPY GROWTH CORP CGC | $17.1k0.00% | Reduced -12.0k |
| RANI THERAPEUTICS HLDGS INC RANI | $15.7k0.00% | Reduced -57.3k |
| BEYOND MEAT INC COM | $14.2k0.00% | Unchanged |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| SCHWAB CHARLES CORP SCHW | $371.8m4.0m shares |
| ALPHABET INC GOOG | $285.8m996.2k shares |
| VISA INC V | $254.1m840.7k shares |
| DISNEY WALT CO DIS | $231.5m2.4m shares |
| MASTERCARD INCORPORATED MA | $217.4m435.1k shares |
| MCKESSON CORP MCK | $202.8m234.3k shares |
| CENTESSA PHARMACEUTICALS PLC | $191.0m4.8m shares |
| TYRA BIOSCIENCES INC TYRA | $137.1m3.6m shares |
| TENET HEALTHCARE CORP THC | $85.3m452.2k shares |
| CARDINAL HEALTH INC CAH | $77.8m368.0k shares |
| VAXCYTE INC PCVX | $73.3m1.3m shares |
| DIANTHUS THERAPEUTICS INC DNTH | $70.2m836.0k shares |
| CG ONCOLOGY INC CGON | $45.6m674.0k shares |
| BITWISE 10 CRYPTO INDEX ETF BITW | $26.9m603.0k shares |
| ROYALTY PHARMA PLC RPRX | $23.6m493.0k shares |
| CECO ENVIRONMENTAL CORP CECO | $13.9m234.0k shares |
| GDS HLDGS LTD GDS | $11.8m292.0k shares |
| FORMFACTOR INC FORM | $5.5m56.5k shares |
| MASTEC INC MTZ | $5.5m17.0k shares |
| ENTEGRIS INC ENTG | $5.3m45.5k shares |
| CITIGROUP INC C | $5.3m47.0k shares |
| HYATT HOTELS CORP H | $5.2m36.0k shares |
| WESTERN ALLIANCE BANCORP WAL | $5.2m73.0k shares |
| TIMKEN CO TKR | $5.1m51.0k shares |
| FLEX LTD FLEX | $5.1m78.0k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR S&P 500 ETF TR SPY · Put | $4.5bn6.0m shares | Added |
| ISHARES TR SOXX · Put | $83.3m130.0k shares | Not comparable |
| CG ONCOLOGY INC CGON · Call | $28.4m400.0k shares | Added |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| PROTAGONIST THERAPEUTICS INC PTGX · 13G · filed 2026-08-13 | 10.0%≈ $788.6m |
| BEAM THERAPEUTICS INC BEAM · 13G · filed 2026-08-13 | 10.0%≈ $352.9m |
| AGIOS PHARMACEUTICALS INC AGIO · 13G · filed 2026-08-03 | 9.9%≈ $219.6m |
| TANGO THERAPEUTICS INC TNGX · 13G · filed 2026-08-14 | 9.8%≈ $508.6m |
| MINERVA NEUROSCIENCES INC NERV · 13G · filed 2026-08-13 | 9.7%≈ $26.3m |
| GRAIL INC GRAL · 13G · filed 2026-08-13 | 9.6%≈ $284.1m |
| LIQUIDIA CORPORATION LQDA · 13G · filed 2026-08-04 | 9.4%≈ $666.9m |
| PERSPECTIVE THERAPEUTICS INC ISR · 13G · filed 2026-08-13 | 8.6% |
| CRINETICS PHARMACEUTICALS IN CRNX · 13G · filed 2026-08-03 | 8.5%≈ $336.4m |
| ENANTA PHARMACEUTICALS INC ENTA · 13G · filed 2026-08-14 | 8.3%≈ $35.3m |
| ASSEMBLY BIOSCIENCES INC ASMB · 13G · filed 2026-08-04 | 8.1%≈ $44.1m |
| SAVARA INC SVRA · 13G · filed 2026-08-14 | 6.8%≈ $92.4m |
| REVOLUTION MEDICINES INC RVMD · 13G · filed 2026-08-13 | 6.4%≈ $2.5bn |
| EXELIXIS INC EXEL · 13D · filed 2026-08-14 | 5.6%≈ $761.1m |
| BRIDGEBIO PHARMA INC BBIO · 13G · filed 2026-08-03 | 5.5%≈ $800.1m |